ArticleBMC ophthalmology2026
Clinical characteristics and surgical outcomes of full-thickness macular hole secondary to retinal vein occlusion.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo describe the clinical characteristics and visual and anatomical surgical prognosis for full-thickness macular hole (FTMH) secondary to retinal vein occlusion (RVO).
methodThis retrospective study reviewed 13 eyes from 13 consecutive patients with FTMH after RVO who underwent pars plana vitrectomy (PPV) combined internal limiting membrane (ILM) peeling or ILM flap insertion. Clinical demographics and spectral-domain optical coherence tomography (SD-OCT) features were evaluated. Multiple linear regression was used to analyze the associated factors for the final best-corrected visual acuity (BCVA).
resultsOf the 13 eyes, 11 had a previous branch RVO (BRVO) and 2 had a central RVO (CRVO). The mean minimum linear diameter (MLD) of these secondary macular holes was 469.31 ± 197.96 μm. Eight subjects (61.5%) showed a FTMH secondary to a long-standing RVO (RVO episode longer than 6 months), and the rest 5 subjects (38.5%) developed a FTMH after a recent onset RVO within 6 months. The two groups shared similar baseline BCVA (P = 0.414), MLD (P = 0.218), and BD (P = 0.453). The mean follow-up period was 10.0 months. All cases showed anatomical closure at the last follow-up, with BCVA significantly improved from 0.90 ± 0.28 logMAR at baseline to 0.45 ± 0.34 logMAR after surgery (P<0.001). The final BCVA of the eyes after recent onset RVO was better than the ones after long-standing RVO (P = 0.012). Regression analysis showed that the final BCVA was significantly associated with the baseline BCVA, RVO duration, and the ellipsoid zone (EZ) integrity (P<0.001).
conclusionFTMH secondary to RVO could achieve favorable anatomical and visual acuity success with PPV. The cases secondary to a recent RVO might have a better visual prognosis. The initial BCVA and postoperative EZ recovery were associated with the final BCVA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.